iShares Biotechnology ETF
IBB
IBB
646 hedge funds and large institutions have $5.66B invested in iShares Biotechnology ETF in 2019 Q2 according to their latest regulatory filings, with 68 funds opening new positions, 182 increasing their positions, 247 reducing their positions, and 82 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
646
Holders Change
-24
Holders Change %
-3.58%
% of All Funds
14.05%
Holding in Top 10
14
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-6.67%
% of All Funds
0.3%
New
68
Increased
182
Reduced
247
Closed
82
Calls
$560M
Puts
$859M
Net Calls
-$299M
Net Calls Change
-$113M
Top Buyers
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$313M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$183M |
| 3 |
JPMorgan Chase & Co
New York
|
+$64.8M |
| 4 |
TEE
Tibra Equities Europe
London,
United Kingdom
|
+$58.9M |
| 5 |
N
Natixis
Paris,
France
|
+$54.6M |
Top Sellers
| 1 |
Goldman Sachs
New York
|
-$123M |
| 2 |
DFO
Duquesne Family Office
New York
|
-$88.5M |
| 3 |
AllianceBernstein
Nashville,
Tennessee
|
-$82.4M |
| 4 |
Morgan Stanley
New York
|
-$66.2M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$55.2M |
